Zobrazeno 1 - 10
of 186
pro vyhledávání: '"Thor, Petersen"'
Autor:
Anders Toftegaard Boysen, Bradley Whitehead, Anne Louise S. Revenfeld, Dhanu Gupta, Thor Petersen, Peter Nejsum
Publikováno v:
Stem Cell Research & Therapy, Vol 15, Iss 1, Pp 1-12 (2024)
Abstract Background Mesenchymal stromal cell (MSC) therapy holds great potential yet efficacy and safety concerns with cell therapy persist. The beneficial effects of MSCs are often attributed to their secretome that includes extracellular vesicles (
Externí odkaz:
https://doaj.org/article/f65f2ed2c53a4728b3f2f9b003684449
Autor:
Julie Schjødtz Hansen, Fernando Boix, Jørgen Bo Hasselstrøm, Lambert Kristiansen Sørensen, Mads Kjolby, Stefan Gustavsen, Rikke Middelhede Hansen, Thor Petersen, Finn Sellebjerg, Helge Kasch, Peter Vestergaard Rasmussen, Nanna Brix Finnerup, Eva Aggerholm Sædder, Kristina Bacher Svendsen
Publikováno v:
Clinical and Translational Science, Vol 17, Iss 1, Pp n/a-n/a (2024)
Abstract Information on the pharmacokinetics (PK) and pharmacodynamics (PD) of orally administered cannabis‐based medicine (CBM) in capsule formulation in patient populations is sparse. In this exploratory study, we aimed to evaluate the PK and PD
Externí odkaz:
https://doaj.org/article/10dc6ec2cd884a1fa87cd0080298e519
Autor:
Harald Hegen, Klaus Berek, Paola Cavalla, Mikael Christiansen, Andreja Emeršič, Massimiliano Di Filippo, Lorenzo Gaetani, Michaela Hassler, Cyra Leurs, Dejan Milosavljevic, Vincent van Pesch, Thor Petersen, Stefan Presslauer, Igal Rosenstein, Uroš Rot, Christine Schnabl, Charlotte Teunissen, Domizia Vecchio, Marco Vercellino, Florian Deisenhammer
Publikováno v:
Frontiers in Immunology, Vol 14 (2023)
BackgroundKappa free light chains (κ-FLC) in the cerebrospinal fluid (CSF) are an emerging biomarker in multiple sclerosis (MS).ObjectiveTo investigate whether κ-FLC index has similar diagnostic value in patients with primary progressive multiple s
Externí odkaz:
https://doaj.org/article/f2268023c7d1409780b691eaa832cee5
Publikováno v:
Clinical Epidemiology, Vol Volume 14, Pp 521-542 (2022)
Charlotte Thor Petersen,1,2 Kristoffer Jarlov Jensen,1 Mary Rosenzweig,2 Benedikte Irene von Osmanski,1,2 Mikkel Zöllner Ankarfeldt,1 Janne Petersen1,3 1Copenhagen Phase IV Unit (Phase4CPH), Copenhagen University Hospital Bispebjerg and Frederiksber
Externí odkaz:
https://doaj.org/article/362df6b60d2340f4bac247e3eb811345
Autor:
Julie Schjødtz Hansen, Stefan Gustavsen, Homayoun Roshanisefat, Matthias Kant, Fin Biering-Sørensen, Claus Andersen, Anna Olsson, Helene Højsgaard Chow, Nasrin Asgari, Julie Richter Hansen, Helle Hvilsted Nielsen, Rikke Middelhede Hansen, Thor Petersen, Annette Bang Oturai, Finn Sellebjerg, Eva Aggerholm Sædder, Helge Kasch, Peter Vestergaard Rasmussen, Nanna Brix Finnerup, Kristina Bacher Svendsen
Publikováno v:
Pharmaceuticals, Vol 16, Iss 8, p 1079 (2023)
Patients with multiple sclerosis (MS) and spinal cord injury (SCI) commonly sustain central neuropathic pain (NP) and spasticity. Despite a lack of consistent evidence, cannabis-based medicine (CBM) has been suggested as a supplement treatment. We ai
Externí odkaz:
https://doaj.org/article/4eaeb1d85b0443b5ac6c45703acf19c2
Publikováno v:
Clinical Case Reports, Vol 9, Iss 8, Pp n/a-n/a (2021)
Abstract Tractopathy lesions in the spinal cord associated with HCV infection, which normalized on MRI after antiviral treatment, are described. These specific MRI findings can be used in the diagnosis and treatment of secondary causes of transverse
Externí odkaz:
https://doaj.org/article/a3439a30eac240d7a34e5800bde44dcc
Autor:
Egon Stenager, Ulrik Dalgas, Morten Riemenschneider, Lars G Hvid, Steffen Ringgaard, Mikkel K E Nygaard, Simon F Eskildsen, Thor Petersen
Publikováno v:
BMJ Open, Vol 11, Iss 1 (2021)
Introduction In the relapsing remitting type of multiple sclerosis (MS) reducing relapses and neurodegeneration is crucial in halting the long-term impact of the disease. Medical disease-modifying treatments have proven effective, especially when int
Externí odkaz:
https://doaj.org/article/011de7348b2740fd8932e3b771f1658d
Autor:
Izanne Roos, Ibrahima Diouf, Sifat Sharmin, Dana Horakova, Eva Kubala Havrdova, Francesco Patti, Vahid Shaygannejad, Serkan Ozakbas, Guillermo Izquierdo, Sara Eichau, Marco Onofrj, Alessandra Lugaresi, Raed Alroughani, Alexandre Prat, Marc Girard, Pierre Duquette, Murat Terzi, Cavit Boz, Francois Grand’Maison, Patrizia Sola, Diana Ferraro, Pierre Grammond, Recai Turkoglu, Katherine Buzzard, Olga Skibina, Bassem Yamou, Ayse Altintas, Oliver Gerlach, Vincent van Pesch, Yolanda Blanco, Davide Maimone, Jeannette Lechner-Scott, Roberto Bergamaschi, Rana Karabudak, Chris McGuigan, Elisabetta Cartechini, Michael Barnett, Stella Hughes, Maria José Sa, Claudio Solaro, Cristina Ramo-Tello, Suzanne Hodgkinson, Daniele Spitaleri, Aysun Soysal, Thor Petersen, Franco Granella, Koen de Gans, Pamela McCombe, Radek Ampapa, Bart Van Wijmeersch, Anneke van der Walt, Helmut Butzkueven, Julie Prevost, Jose Luis Sanchez-Menoyo, Guy Laureys, Riadh Gouider, Tamara Castillo-Triviño, Orla Gray, Eduardo Aguera-Morales, Abdullah Al-Asmi, Cameron Shaw, Norma Deri, Talal Al-Harbi, Yara Fragoso, Tunde Csepany, Angel Perez Sempere, Irene Trevino-Frenk, Jan Schepel, Fraser Moore, Charles Malpas, Tomas Kalincik
Publikováno v:
Multiple Sclerosis., Vol. 29, no.3, p. 326-332 (2023)
Background: In the absence of evidence from randomised controlled trials, observational data can be used to emulate clinical trials and guide clinical decisions. Observational studies are, however, susceptible to confounding and bias. Among the used
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::c811efad796f14a285bd504765bfa637
https://doi.org/10.1177/13524585231151394
https://doi.org/10.1177/13524585231151394
Autor:
Julie Schjødtz Hansen, Rikke Middelhede Hansen, Thor Petersen, Stefan Gustavsen, Annette Bang Oturai, Finn Sellebjerg, Eva Aggerholm Sædder, Helge Kasch, Peter Vestergaard Rasmussen, Nanna Brix Finnerup, Kristina Bacher Svendsen
Publikováno v:
Brain Sciences, Vol 11, Iss 9, p 1212 (2021)
Disease or acquired damage to the central nervous system frequently causes disabling spasticity and central neuropathic pain (NP), both of which are frequent in multiple sclerosis (MS) and spinal cord injury (SCI). Patients with MS and SCI often requ
Externí odkaz:
https://doaj.org/article/18643a4514d24dccb74862a584661049
Publikováno v:
Riemenschneider, M, Hvid, L G, Petersen, T, Stenager, E & Dalgas, U 2023, ' Exercise Therapy in Early Multiple Sclerosis Improves Physical Function But Not Cognition : Secondary Analyses From a Randomized Controlled Trial ', Neurorehabilitation and Neural Repair, vol. 37, no. 5, pp. 288-297 . https://doi.org/10.1177/15459683231159659
Background Exercise positively affects multiple sclerosis (MS) symptoms, physiological systems, and potentially cognition. However, an uninvestigated “window of opportunity” exists for exercise therapy early in the disease. Objective This study p
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::9e66e36efe8d0a01838a581f9f259911
https://pure.au.dk/portal/da/publications/exercise-therapy-in-early-multiple-sclerosis-improves-physical-function-but-not-cognition(ed21bfb6-1102-43cc-a793-23acba0cd036).html
https://pure.au.dk/portal/da/publications/exercise-therapy-in-early-multiple-sclerosis-improves-physical-function-but-not-cognition(ed21bfb6-1102-43cc-a793-23acba0cd036).html
